OpenFilings

EyePoint Pharmaceuticals, Inc.

Form10-K/A

Report Period2020-12-31

Date Filed2021-05-04

Time Filed09:04:11

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-31.3
EX-31.4
Filing on SEC Edgar